These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3176505)

  • 21. Prognostic significance of CEA levels and positive cytology in peritoneal washings in patients with colorectal cancer.
    Kanellos I; Zacharakis E; Kanellos D; Pramateftakis MG; Betsis D
    Colorectal Dis; 2006 Jun; 8(5):436-40. PubMed ID: 16684089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative follow-up for colorectal cancer: who are we kidding?
    Ballantyne GH; Modlin IM
    J Clin Gastroenterol; 1988 Aug; 10(4):359-64. PubMed ID: 3418082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prospective follow-up study of radically resected colorectal carcinoma. Status after 5 years].
    Metzger U; Bronz K; Bühler H; Dolder A; Seefeld U; Hollinger A; Largiadèr F
    Schweiz Med Wochenschr; 1985 Jul; 115(29):1001-4. PubMed ID: 4048893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study.
    Hara M; Kanemitsu Y; Hirai T; Komori K; Kato T
    Dis Colon Rectum; 2008 Nov; 51(11):1675-80. PubMed ID: 18633674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The chemoradiotherapy of advanced colorectal carcinoma--the results and toxicity in a pilot study with 44 patients].
    Brockmann WP; Wiegel T; Sommer K; Steiner P; Hübener KH
    Strahlenther Onkol; 1993 Feb; 169(2):107-13. PubMed ID: 8451725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postsurgical surveillance for recurrence of UICC stage I colorectal carcinoma: is follow-up by CEA justified?
    Yamamoto S; Akasu T; Fujita S; Moriya Y
    Hepatogastroenterology; 2005; 52(62):444-9. PubMed ID: 15816454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.
    Takagawa R; Fujii S; Ohta M; Nagano Y; Kunisaki C; Yamagishi S; Osada S; Ichikawa Y; Shimada H
    Ann Surg Oncol; 2008 Dec; 15(12):3433-9. PubMed ID: 18846401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serological markers of colorectal cancer].
    Nielsen HJ; Christensen IJ; Brünner NA
    Ugeskr Laeger; 2005 Oct; 167(44):4163-7. PubMed ID: 16266568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Colorectal cancers: adjuvant therapy and after care (including tumor markers)].
    Laffer U; Harder F
    Ther Umsch; 1991 Jul; 48(7):449-55. PubMed ID: 1926004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CEA, CA 50 and CA 242 in patients surviving colorectal cancer without recurrent disease.
    Engarås B; Kewenter J; Nilsson O; Wedel H; Hafström L
    Eur J Surg Oncol; 2001 Feb; 27(1):43-8. PubMed ID: 11237491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Increased carcinoembryonic antigen and absence of recurrence in monitoring colorectal cancer].
    Forones NM; Tanaka M; Machado D
    Arq Gastroenterol; 1998; 35(2):100-3. PubMed ID: 9814374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging techniques contribute to increased surgical rescue of relapse in the follow-up of colorectal cancer.
    Arriola E; Navarro M; Parés D; Muñoz M; Pareja L; Figueras J; Soler G; Martinez M; Majem M; Germa-Lluch JR
    Dis Colon Rectum; 2006 Apr; 49(4):478-84. PubMed ID: 16450212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of liver and lung metastases from colorectal cancer].
    Burcharth F; Jensen BV
    Ugeskr Laeger; 2005 Nov; 167(45):4268-72. PubMed ID: 16277926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer.
    Griesenberg D; Nürnberg R; Bahlo M; Klapdor R
    Anticancer Res; 1999; 19(4A):2443-50. PubMed ID: 10470173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diagnosis and therapy of metastatic and recurrent colorectal tumors].
    Köves I; Besznyák I; Molnár L; Vámosi-Nagy I
    Orv Hetil; 1990 Mar; 131(11):559-62. PubMed ID: 1690376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic criteria and risk groups in colorectal cancer].
    Mentges B; Brückner R
    Wien Med Wochenschr; 1988 Jul; 138(13):317-22. PubMed ID: 3188544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic accuracy of serial CT/magnetic resonance imaging review vs. positron emission tomography/CT in colorectal cancer patients with suspected and known recurrence.
    Potter KC; Husband JE; Houghton SL; Thomas K; Brown G
    Dis Colon Rectum; 2009 Feb; 52(2):253-9. PubMed ID: 19279420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
    Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
    Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
    Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
    Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antigens (CEA and CA 19-9) in diagnosis and prognosis colorectal cancer].
    Grotowski M
    Pol Merkur Lekarski; 2002 Jan; 12(67):77-80. PubMed ID: 11957811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.